We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The future of Avastin (bevacizumab) as a breast cancer therapy took another turn when a major organization of cancer specialists voted to continue its support for the indication. MedPage Today
